NM_001379200.1:c.1380T>C

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001379200.1(TBX1):​c.1380T>C​(p.His460His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000895 in 1,541,462 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00082 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00090 ( 3 hom. )

Consequence

TBX1
NM_001379200.1 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.0100
Variant links:
Genes affected
TBX1 (HGNC:11592): (T-box transcription factor 1) This gene is a member of a phylogenetically conserved family of genes that share a common DNA-binding domain, the T-box. T-box genes encode transcription factors involved in the regulation of developmental processes. This gene product shares 98% amino acid sequence identity with the mouse ortholog. DiGeorge syndrome (DGS)/velocardiofacial syndrome (VCFS), a common congenital disorder characterized by neural-crest-related developmental defects, has been associated with deletions of chromosome 22q11.2, where this gene has been mapped. Studies using mouse models of DiGeorge syndrome suggest a major role for this gene in the molecular etiology of DGS/VCFS. Several alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 22-19766732-T-C is Benign according to our data. Variant chr22-19766732-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 518488.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.01 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000822 (124/150886) while in subpopulation AMR AF= 0.00263 (40/15198). AF 95% confidence interval is 0.00199. There are 1 homozygotes in gnomad4. There are 66 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 124 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TBX1NM_001379200.1 linkc.1380T>C p.His460His synonymous_variant Exon 7 of 7 ENST00000649276.2 NP_001366129.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TBX1ENST00000649276.2 linkc.1380T>C p.His460His synonymous_variant Exon 7 of 7 NM_001379200.1 ENSP00000497003.1 A0A3B3IS18
TBX1ENST00000332710.8 linkc.1353T>C p.His451His synonymous_variant Exon 9 of 9 1 ENSP00000331791.4 O43435-3
TBX1ENST00000329705.11 linkc.1009+730T>C intron_variant Intron 8 of 8 1 ENSP00000331176.7 O43435-1
TBX1ENST00000359500.7 linkc.1009+730T>C intron_variant Intron 8 of 9 1 ENSP00000352483.3 O43435-2

Frequencies

GnomAD3 genomes
AF:
0.000829
AC:
125
AN:
150780
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000196
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00264
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00187
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00323
Gnomad NFE
AF:
0.000975
Gnomad OTH
AF:
0.000484
GnomAD3 exomes
AF:
0.000664
AC:
113
AN:
170270
Hom.:
2
AF XY:
0.000813
AC XY:
79
AN XY:
97122
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000396
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00185
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000721
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000903
AC:
1256
AN:
1390576
Hom.:
3
Cov.:
33
AF XY:
0.000937
AC XY:
648
AN XY:
691514
show subpopulations
Gnomad4 AFR exome
AF:
0.000139
Gnomad4 AMR exome
AF:
0.000410
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00180
Gnomad4 FIN exome
AF:
0.0000551
Gnomad4 NFE exome
AF:
0.000961
Gnomad4 OTH exome
AF:
0.000733
GnomAD4 genome
AF:
0.000822
AC:
124
AN:
150886
Hom.:
1
Cov.:
33
AF XY:
0.000895
AC XY:
66
AN XY:
73728
show subpopulations
Gnomad4 AFR
AF:
0.000195
Gnomad4 AMR
AF:
0.00263
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00187
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000975
Gnomad4 OTH
AF:
0.000478
Alfa
AF:
0.0000540
Hom.:
0
Bravo
AF:
0.000797
Asia WGS
AF:
0.000291
AC:
1
AN:
3454

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

TBX1: BP4, BP7 -

Jan 21, 2021
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Dec 08, 2017
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:1
Jun 17, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

DiGeorge syndrome Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Cardiovascular phenotype Benign:1
Jun 24, 2015
Ambry Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
7.5
DANN
Benign
0.35

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs367711718; hg19: chr22-19754255; API